Skip to main content

Table 1 Baseline characteristics

From: Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604

 

Phase I

Phase II

Number of patients

12

35*

Age (years)

 median

72

75

 range

70–81

70–86

Sex

 male

9

75%

25

71%

 female

3

25%

10

29%

ECOG PS

 0/1/2

8/4/0

17/17/1

TNM factors

 T 1/2/3/4

2/6/0/4

10/14/5/6

 N 0/1/2/3

0/4/5/3

2/8/17/8

Brinkman’s index

 median

1000

1000

 range

0–3600

0–2950

  1. ECOG PS Eastern Cooperative Oncology Group Performance Status
  2. Asterisk: including 6 patients who recieved level 1 treatment at phase I portion